These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

562 related items for PubMed ID: 35716254

  • 1. Systemic Sclerosis-Specific Antibodies: Novel and Classical Biomarkers.
    Cavazzana I, Vojinovic T, Airo' P, Fredi M, Ceribelli A, Pedretti E, Lazzaroni MG, Garrafa E, Franceschini F.
    Clin Rev Allergy Immunol; 2023 Jun; 64(3):412-430. PubMed ID: 35716254
    [Abstract] [Full Text] [Related]

  • 2. Recognising the spectrum of scleromyositis: HEp-2 ANA patterns allow identification of a novel clinical subset with anti-SMN autoantibodies.
    Landon-Cardinal O, Baril-Dionne A, Hoa S, Meyer A, Leclair V, Bourré-Tessier J, Mansour AM, Zarka F, Makhzoum JP, Nehme J, Rich E, Goulet JR, Grodzicky T, Koenig M, Joyal F, Richard I, Hudson M, Targoff I, Satoh M, Fritzler MJ, Troyanov Y, Senécal JL.
    RMD Open; 2020 Sep; 6(2):. PubMed ID: 32892170
    [Abstract] [Full Text] [Related]

  • 3. Autoantibody profiles in systemic sclerosis: predictive value for clinical evaluation and prognosis.
    Hamaguchi Y.
    J Dermatol; 2010 Jan; 37(1):42-53. PubMed ID: 20175839
    [Abstract] [Full Text] [Related]

  • 4. Frequency of disease-associated and other nuclear autoantibodies in patients of the German Network for Systemic Scleroderma: correlation with characteristic clinical features.
    Mierau R, Moinzadeh P, Riemekasten G, Melchers I, Meurer M, Reichenberger F, Buslau M, Worm M, Blank N, Hein R, Müller-Ladner U, Kuhn A, Sunderkötter C, Juche A, Pfeiffer C, Fiehn C, Sticherling M, Lehmann P, Stadler R, Schulze-Lohoff E, Seitz C, Foeldvari I, Krieg T, Genth E, Hunzelmann N.
    Arthritis Res Ther; 2011 Jan; 13(5):R172. PubMed ID: 22018289
    [Abstract] [Full Text] [Related]

  • 5. Autoantibodies to RuvBL1 and RuvBL2: a novel systemic sclerosis-related antibody associated with diffuse cutaneous and skeletal muscle involvement.
    Kaji K, Fertig N, Medsger TA, Satoh T, Hoshino K, Hamaguchi Y, Hasegawa M, Lucas M, Schnure A, Ogawa F, Sato S, Takehara K, Fujimoto M, Kuwana M.
    Arthritis Care Res (Hoboken); 2014 Apr; 66(4):575-84. PubMed ID: 24023044
    [Abstract] [Full Text] [Related]

  • 6. Anti-U11/U12 Antibodies as a Rare but Important Biomarker in Patients with Systemic Sclerosis: A Narrative Review.
    Fritzler MJ, Bentow C, Beretta L, Palterer B, Perurena-Prieto J, Sanz-Martínez MT, Guillen-Del-Castillo A, Marín A, Fonollosa-Pla V, Callejas-Moraga E, Simeón-Aznar CP, Mahler M.
    Diagnostics (Basel); 2023 Mar 27; 13(7):. PubMed ID: 37046475
    [Abstract] [Full Text] [Related]

  • 7. Clinical and laboratory features of African-Brazilian patients with systemic sclerosis.
    Mendes C, Viana VST, Pasoto SG, Leon EP, Bonfa E, Sampaio-Barros PD.
    Clin Rheumatol; 2020 Jan 27; 39(1):9-17. PubMed ID: 31065858
    [Abstract] [Full Text] [Related]

  • 8. Predicting cardiopulmonary involvement in patients with systemic sclerosis: complementary value of nailfold videocapillaroscopy patterns and disease-specific autoantibodies.
    Markusse IM, Meijs J, de Boer B, Bakker JA, Schippers HPC, Schouffoer AA, Ajmone Marsan N, Kroft LJM, Ninaber MK, Huizinga TWJ, de Vries-Bouwstra JK.
    Rheumatology (Oxford); 2017 Jul 01; 56(7):1081-1088. PubMed ID: 27940596
    [Abstract] [Full Text] [Related]

  • 9. A subset of systemic sclerosis but not of systemic lupus erythematosus is defined by isolated anti-Ku autoantibodies.
    Cavazzana I, Fredi M, Taraborelli M, Quinzanini M, Tincani A, Franceschini F.
    Clin Exp Rheumatol; 2013 Jul 01; 31(2 Suppl 76):118-21. PubMed ID: 23910615
    [Abstract] [Full Text] [Related]

  • 10. Clinical Features of Systemic Sclerosis-Mixed Connective Tissue Disease and Systemic Sclerosis Overlap Syndromes.
    Fairley JL, Hansen D, Proudman S, Sahhar J, Ngian GS, Walker J, Strickland G, Wilson M, Morrisroe K, Ferdowsi N, Major G, Roddy J, Stevens W, Nikpour M, Australian Scleroderma Interest Group.
    Arthritis Care Res (Hoboken); 2021 May 01; 73(5):732-741. PubMed ID: 32058672
    [Abstract] [Full Text] [Related]

  • 11. Presence of anti-eukaryotic initiation factor-2B, anti-RuvBL1/2 and anti-synthetase antibodies in patients with anti-nuclear antibody negative systemic sclerosis.
    Pauling JD, Salazar G, Lu H, Betteridge ZE, Assassi S, Mayes MD, McHugh NJ.
    Rheumatology (Oxford); 2018 Apr 01; 57(4):712-717. PubMed ID: 29294089
    [Abstract] [Full Text] [Related]

  • 12. Anti-U11/U12 RNP antibodies in systemic sclerosis: a new serologic marker associated with pulmonary fibrosis.
    Fertig N, Domsic RT, Rodriguez-Reyna T, Kuwana M, Lucas M, Medsger TA, Feghali-Bostwick CA.
    Arthritis Rheum; 2009 Jul 15; 61(7):958-65. PubMed ID: 19565553
    [Abstract] [Full Text] [Related]

  • 13. [Autoantibodies in systemic sclerosis: clinical interest and diagnosis approach].
    Admou B, Essaadouni L, Amal S, Arji N, Chabaa L, El Aouad R.
    Ann Biol Clin (Paris); 2009 Jul 15; 67(3):273-81. PubMed ID: 19411229
    [Abstract] [Full Text] [Related]

  • 14. [Autoantibodies and their clinical characteristics in systemic sclerosis].
    Hamaguchi Y.
    Nihon Rinsho Meneki Gakkai Kaishi; 2013 Jul 15; 36(3):139-47. PubMed ID: 23812071
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Joint contractures responsive to immunosuppressive therapy in a girl with childhood-onset systemic sclerosis double-seropositive for rare anti-nucleolar autoantibodies: a case report.
    Tanaka R, Tani Y, Kaburaki Y, Kinoshita M, Kawaguchi Y, Okazaki Y, Kuwana M, Harigai M, Nagata S, Miyamae T.
    Pediatr Rheumatol Online J; 2021 Mar 20; 19(1):37. PubMed ID: 33743728
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Distinctive autoantibody profile in Mexican Mestizo systemic sclerosis patients.
    Rodriguez-Reyna TS, Hinojosa-Azaola A, Martinez-Reyes C, Nuñez-Alvarez CA, Torrico-Lavayen R, García-Hernández JL, Cabiedes-Contreras J.
    Autoimmunity; 2011 Nov 20; 44(7):576-84. PubMed ID: 21875377
    [Abstract] [Full Text] [Related]

  • 19. The clinical relevance of autoantibodies in scleroderma.
    Ho KT, Reveille JD.
    Arthritis Res Ther; 2003 Nov 20; 5(2):80-93. PubMed ID: 12718748
    [Abstract] [Full Text] [Related]

  • 20. The prevalence and significance of anti-PM/Scl antibodies in systemic sclerosis.
    Wielosz E, Dryglewska M, Majdan M.
    Ann Agric Environ Med; 2021 Mar 18; 28(1):189-192. PubMed ID: 33775087
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.